BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 16134309)

  • 1. Correlative study of angiogenesis and dynamic contrast-enhanced magnetic resonance imaging features of hepatocellular carcinoma.
    Wang B; Gao ZQ; Yan X
    Acta Radiol; 2005 Jul; 46(4):353-8. PubMed ID: 16134309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-level dynamic spiral CT of hepatocellular carcinoma: correlation between imaging features and density of tumor microvessels.
    Chen WX; Min PQ; Song B; Xiao BL; Liu Y; Ge YH
    World J Gastroenterol; 2004 Jan; 10(1):67-72. PubMed ID: 14695771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
    Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
    Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative free-breathing dynamic contrast-enhanced MRI in hepatocellular carcinoma using gadoxetic acid: correlations with Ki67 proliferation status, histological grades, and microvascular density.
    Chen J; Chen C; Xia C; Huang Z; Zuo P; Stemmer A; Song B
    Abdom Radiol (NY); 2018 Jun; 43(6):1393-1403. PubMed ID: 28939963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging in hepatocellular carcinoma: correlations between MRI features and molecular marker VEGF.
    Huang Z; Meng X; Xiu J; Xu X; Bi L; Zhang J; Han X; Liu Q
    Med Oncol; 2014 Dec; 31(12):313. PubMed ID: 25367856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
    Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
    Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
    Wang YC; Chou CT; Lin CP; Chen YL; Chen YF; Chen RC
    PLoS One; 2017; 12(3):e0174594. PubMed ID: 28355258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D dynamic contrast-enhanced MRI of rectal carcinoma at 3T: correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis.
    Zhang XM; Yu D; Zhang HL; Dai Y; Bi D; Liu Z; Prince MR; Li C
    J Magn Reson Imaging; 2008 Jun; 27(6):1309-16. PubMed ID: 18504761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging and expression of vascular endothelial growth factor in hepatocellular nodules in cirrhosis and hepatocellular carcinomas.
    Kanematsu M; Semelka RC; Osada S; Amaoka N
    Top Magn Reson Imaging; 2005 Feb; 16(1):67-75. PubMed ID: 16314697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?
    Moon WS; Rhyu KH; Kang MJ; Lee DG; Yu HC; Yeum JH; Koh GY; Tarnawski AS
    Mod Pathol; 2003 Jun; 16(6):552-7. PubMed ID: 12808060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
    Yang LY; Lu WQ; Huang GW; Wang W
    BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.
    Murakami K; Kasajima A; Kawagishi N; Sekiguchi S; Fujishima F; Watanabe M; Sato Y; Ohuchi N; Sasano H
    Hum Pathol; 2014 Mar; 45(3):589-97. PubMed ID: 24444468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
    Tseng PL; Tai MH; Huang CC; Wang CC; Lin JW; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    J Surg Oncol; 2008 Oct; 98(5):349-57. PubMed ID: 18646041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging features for improved diagnosis of hepatocellular carcinoma in the non-cirrhotic liver: Multi-center evaluation.
    Fischer MA; Raptis DA; Donati OF; Hunziker R; Schade E; Sotiropoulos GC; McCall J; Bartlett A; Bachellier P; Frilling A; Breitenstein S; Clavien PA; Alkadhi H; Patak MA
    Eur J Radiol; 2015 Oct; 84(10):1879-87. PubMed ID: 26194029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology.
    Grazioli L; Olivetti L; Fugazzola C; Benetti A; Stanga C; Dettori E; Gallo C; Matricardi L; Giacobbe A; Chiesa A
    Eur Radiol; 1999; 9(1):62-7. PubMed ID: 9933382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.
    Nakamura S; Nakaura T; Kidoh M; Utsunomiya D; Doi Y; Harada K; Uemura S; Yamashita Y
    J Magn Reson Imaging; 2013 Sep; 38(3):548-54. PubMed ID: 23744782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival.
    Huang GW; Yang LY; Lu WQ
    World J Gastroenterol; 2005 Mar; 11(11):1705-8. PubMed ID: 15786555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging Biomarkers of Angiogenesis.
    Kim SH; Lee HS; Kang BJ; Song BJ; Kim HB; Lee H; Jin MS; Lee A
    PLoS One; 2016; 11(12):e0168632. PubMed ID: 28036342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.